Efficacy and Safety of ALT-801 in the Treatment of Obesity
Trial details
- Registry ID
- NCT05295875
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Efficacy and Safety of ALT-801 in the Treatment of ObesityNCT05295875 | ALT | Phase 2 | Completed | 2023-09-28Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |